s6y
Company name or ticker
Search
Cellectar Biosciences, Inc.
3
Chanan-Khan Asher: Initial statement of beneficial ownership of securities
Filed
Friday, July 2, 2021
Period
Jun 23, 2021
Accession number
0001104659-21-088829
Documents
OWNERSHIP DOCUMENT
3
EXHIBIT 24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header